MEDICAL RESOURCES

PrMavenclad® (Cladribine)

10 mg Tablet

Therapeutic Classification: Selective Immunosuppressant

Treatment with Mavenclad should be initiated and supervised by
neurologists experienced in the treatment of patients with MS and
who have fully familiarized themselves with the efficacy and safety
profile of Mavenclad.

Action SVG
Action SVG
Action SVG